Zhu, Q., Hu, H., Jiang, F., Guo, C. Y., Yang, X. W., Liu, X., & Kuang, Y. K. (2017). Meta-analysis of incidence and risk of severe adverse events and fatal adverse events with crizotinib monotherapy in patients with ALK-positive NSCLC. Oncotarget.

Zhu, Qian, Hao Hu, Feng Jiang, Chang Ying Guo, Xiong Wen Yang, Xi Liu, and Yu Kang Kuang. "Meta-analysis of Incidence and Risk of Severe Adverse Events and Fatal Adverse Events With Crizotinib Monotherapy in Patients With ALK-positive NSCLC." Oncotarget 2017.

Zhu, Qian, et al. "Meta-analysis of Incidence and Risk of Severe Adverse Events and Fatal Adverse Events With Crizotinib Monotherapy in Patients With ALK-positive NSCLC." Oncotarget 2017.